SECURE CLOUD ACCESS

NEWS AND EVENTS

06 ​​​​​​FEB.2017

UNIVERSITY OF MIAMI: NEW STUDY COMPLETED

  The sudomotor response markers of the SweatC device (NO Peak and Sweat Peak) have been investigated. 
The results of the clinical study showed:
NO Peak returns a sensitivity of 88 % and sensitivity of 68% (AUC=0.809 and p. 0.0001) to detect retinopathy.
NO Peak inversely correlates (Spearman coefficient rho= -0.405 and p.0.0001) to the BUN (blood test for the estimate the kidney function)
NO Peak inversely correlates (Spearman coefficient rho= -0.442 p.0.0001) to homocysteine blood tests which are known for identifying B12 or folic acid deficiency.
NO Peak inversely correlates (Spearman coefficient rho= -0.676 p.0.0001) to the Cardiac Autonomic Reflex Tests Score (Carts Score) which is known for identifying  neuropathy
Sweat Peak inversely correlates (Spearman coefficient rho= -0.56 and p.0.0001) to the severity of symptoms of peripheral neuropathy on a scale of 1 to 5.
  
Since retinopathy, kidney disorders, and neuropathy are classified as microvascular diseases, and the B12 supplement is known to improve microcirculation, the sudomotor function marker NO Peak correlations demonstrate that it should be considered as a microcirculation marker.
Since the severity of the C-Fiber damage  induces symptoms, the sudomotor function marker SweatPeak correlation demonstrates that it should be considered as a marker of small fiber neuropathy.
Moreover. the results of the study conclusively elucidate how galvanic skin response technology assesses the sudomotor function.

20 ​​​​​​​​​​​OCT.2016​​

RELEASE TM-FLOW v.2 

TM-Flow version 2 has been released on November 20, 2016.
The updated version has a new design and network options.The report can be sent to a secure cloud for each registered physician or to a server or EMR. The updated version is free for the user under warranty.
Please contact us for online support for installing the new TM-FLOW version. 

26 ​​​​​​​​​​​OCT.2016​​

NEW PUBLICATION PTG SPECTRAL ANALYSIS

 LD Technology is proud to announce a new clinical study of our PTG Spectral Analysis technology has been accepted for publication by The Journal of Diabetes and its Complications ((http://www.jdcjournal.com/). The title of the study is “Assessment of insulin sensitivity by the hyperinsulinemic euglycemic clamp: comparison with the spectral analysis of photoplethysmography"
Here is a link to the study: http://www.jdcjournal.com/article/S1056-8727(16)30731-0/abstract
The excellent results of this clinical study have far exceeded our assumptions, hopes, and expectations. This study clearly shows that our PTG technology markers can accurately identify insulin resistance. " The ROC curves showed that the most relevant cutoff to the whole study group was a PTG-TP > 406.2. This cut-off had a sensitivity = 95.7%, specificity = 84,4% and the area under the ROC curve (AUC) = 0.929 for identifying insulin resistance. All AUC ROC curve analysis were significant (p < 0.0001)"
This is the 4th publication related to our PTG Spectral Analysis Markers, and once again we have shown high specificity and sensitivity to detect all stages of development for diabetes and its complications.
Click here to read the full publication

23 ​​​​​​​​​​​​​​​SEPT.2016​​

RELEASE OF LEDA SYSTEM

LEDA System is a Medical Device Data System (MDDS). Product Code: OUG.
LEDA System integrates the data of volume plethysmography and photoplehysmography analysis, The data are obtained from two devices 1) LD-Oxy and 2) TM-ABI for assessing arterial stiffness, blood pressure and peripheral artery disease (PAD).

13 ​​​​​​​​​​​​​FEB.2016​​

RELEASE OF TM-FLOW

TM-Flow system is a Medical Device Data System (MDDS). Product Code: OUG.
TM-Flow system integrates the data of sudomotor function tests, heart rate variability analysis (both at rest and during Ewing tests), photoplethysmography and volume plethysmography analysis, The data are obtained from three devices 1) SweatC, 2) LD-Oxy and 3) TM-ABI for assessing autonomic nerves (small fiber and cardiac autonomic nerves) microcirculation, arterial stiffness, blood pressure and peripheral artery disease (PAD).